{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:41:47Z","timestamp":1791013307138,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.ymgme.2009.04.013","type":"journal-article","created":{"date-parts":[[2009,5,5]],"date-time":"2009-05-05T09:23:20Z","timestamp":1241515400000},"page":"284-291","source":"Crossref","is-referenced-by-count":28,"title":["Pharmacokinetics, safety and tolerability of miglustat in the treatment of pediatric patients with GM2 gangliosidosis"],"prefix":"10.1016","volume":"97","author":[{"given":"Gustavo H.B.","family":"Maegawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.M.","family":"van Giersbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Banwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper","family":"Dingemanse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia J.","family":"Tifft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe T.R.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2009.04.013_bib1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1517\/13543784.10.3.455","article-title":"Substrate reduction therapy for glycosphingolipid storage disorders","volume":"10","author":"Lachmann","year":"2001","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ymgme.2009.04.013_bib2","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher\u2019s disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2009.04.013_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/bcmd.2002.0497","article-title":"Low-dose N-butyldeoxynojirimycin (OGT 918) for type I Gaucher disease","volume":"28","author":"Heitner","year":"2002","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgme.2009.04.013_bib4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/01.wnl.0000194225.78917.de","article-title":"Substrate reduction therapy in the infantile form of Tay\u2013Sachs disease","volume":"66","author":"Bembi","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2009.04.013_bib5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jchromb.2008.11.040","article-title":"Rapid quantification of miglustat in human plasma and cerebrospinal fluid by liquid chromatography coupled with tandem mass spectrometry","volume":"877","author":"Guitton","year":"2009","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ymgme.2009.04.013_bib6","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","article-title":"Miglustat for treatment of Niemann\u2013Pick C disease: a randomised controlled study","volume":"6","author":"Patterson","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymgme.2009.04.013_bib7","doi-asserted-by":"crossref","first-page":"e1550","DOI":"10.1542\/peds.2006-0588","article-title":"The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported","volume":"118","author":"Maegawa","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2009.04.013_bib8","series-title":"The Metabolic and Molecular Basis of Inherited Disease","first-page":"3827","article-title":"The GM2 gangliosidosis","author":"Gravel","year":"2001"},{"key":"10.1016\/j.ymgme.2009.04.013_bib9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.276.5311.428","article-title":"Prevention of lysosomal storage in Tay\u2013Sachs mice treated with N-butyldeoxynojirimycin","volume":"276","author":"Platt","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2009.04.013_bib10","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1073\/pnas.96.11.6388","article-title":"Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin","volume":"96","author":"Jeyakumar","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2009.04.013_bib11","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/sj.bmt.1705155","article-title":"Allogeneic BMT followed by substrate reduction therapy in a child with subacute Tay\u2013Sachs disease","volume":"36","author":"Jacobs","year":"2005","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymgme.2009.04.013_bib12","unstructured":"B.E. Shapiro, G.M. Pastores, J. Gianutsos, C. Luzy, E.H. Kolodny, Miglustat in late-onset Tay\u2013Sachs disease: a 12-month, randomized, controlled clinical study with 24 months of extended treatment, Genet. Med., [Epub 5 May 2009 ahead of print]."},{"key":"10.1016\/j.ymgme.2009.04.013_bib13","unstructured":"Actelion, ZavescaTM 100 mg hard capsules (miglustat): summary of product characteristics, Actelion Pharmaceuticas Inc. 2006, 2007. Available from: <http:\/\/www.actelion.com>."},{"key":"10.1016\/j.ymgme.2009.04.013_bib14","series-title":"British National Formulary for Children","author":"Commitee","year":"2005"},{"key":"10.1016\/j.ymgme.2009.04.013_bib15","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/0091270007305298","article-title":"Influence of food intake on the pharmacokinetics of miglustat, an inhibitor of glucosylceramide synthase","volume":"47","author":"van Giersbergen","year":"2007","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ymgme.2009.04.013_bib16","unstructured":"NCI, Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS March 31, 2003, National Cancer Institute, 2006."},{"key":"10.1016\/j.ymgme.2009.04.013_bib17","first-page":"647","article-title":"Imiglucerase low-dose therapy for paediatric Gaucher disease\u2014a long-term cohort study","volume":"94","author":"Heitner","year":"2004","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.ymgme.2009.04.013_bib18","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.2165\/00003495-200363220-00006","article-title":"Miglustat","volume":"63","author":"McCormack","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.ymgme.2009.04.013_bib19","series-title":"Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics","article-title":"Pharmacokinetics and pharmacodynamics: the dymamics of drug absorption, distribution, action and elimination","author":"Buxton","year":"2006"},{"key":"10.1016\/j.ymgme.2009.04.013_bib20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1023\/A:1025902113005","article-title":"The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement","volume":"26","author":"Cox","year":"2003","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2009.04.013_bib21","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.clinthera.2005.08.004","article-title":"An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatment","volume":"27","author":"Pastores","year":"2005","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ymgme.2009.04.013_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ajh.20504","article-title":"Guidance on the use of miglustat for treating patients with type 1 Gaucher disease","volume":"80","author":"Weinreb","year":"2005","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ymgme.2009.04.013_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/08035320510028157","article-title":"Substrate reduction therapy for lysosomal storage diseases","volume":"94","author":"Cox","year":"2005","journal-title":"Acta Paediatr. Suppl."},{"key":"10.1016\/j.ymgme.2009.04.013_bib24","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1194\/jlr.M600488-JLR200","article-title":"Lysosomal unesterified cholesterol content correlates with liver cell death in murine Niemann\u2013Pick type C disease","volume":"48","author":"Beltroy","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2009.04.013_bib25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.brainres.2006.11.039","article-title":"Cerebrospinal fluid biomarkers showing neurodegeneration in dogs with GM1 gangliosidosis: possible use for assessment of a therapeutic regimen","volume":"1133","author":"Satoh","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.ymgme.2009.04.013_bib26","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0140-6736(05)62568-8","article-title":"Diagnosis of Alzheimer\u2019s disease with cerebrospinal fluid tau protein and aspartate aminotransferase","volume":"350","author":"Riemenschneider","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2009.04.013_bib27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3181\/00379727-97-23733","article-title":"Cerebrospinal fluid enzymes in central nervous system lipidoses (with particular reference to amaurotic family idiocy)","volume":"97","author":"Aronson","year":"1958","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.ymgme.2009.04.013_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0379-0738(92)90107-8","article-title":"Efficacy of cerebro-spinal fluid biochemistry in the diagnosis of brain insult","volume":"52","author":"Osuna","year":"1992","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.ymgme.2009.04.013_bib29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.amjopharm.2004.09.004","article-title":"Gabapentin: a pooled analysis of adverse events from three clinical trials in patients with postherpetic neuralgia","volume":"2","author":"Parsons","year":"2004","journal-title":"Am. J. Geriatr. Pharmacother."},{"issue":"Suppl. 3","key":"10.1016\/j.ymgme.2009.04.013_bib30","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1111\/j.1528-1157.1987.tb05780.x","article-title":"Carbamazepine side effects in children and adults","volume":"28","author":"Pellock","year":"1987","journal-title":"Epilepsia"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719209001127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719209001127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T04:27:46Z","timestamp":1545280066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719209001127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S1096719209001127"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2009.04.013","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}